Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001564590-20-007973
Filing Date
2020-03-02
Accepted
2020-03-02 07:47:59
Documents
79
Period of Report
2019-12-31

Document Format Files

Seq Description Document Type Size
1 10-K hrtx-10k_20191231.htm   iXBRL 10-K 3776265
2 EX-4.5 hrtx-ex45_232.htm EX-4.5 27750
3 EX-23.1 hrtx-ex231_446.htm EX-23.1 3442
4 EX-31.1 hrtx-ex311_9.htm EX-31.1 19217
5 EX-31.2 hrtx-ex312_8.htm EX-31.2 19460
6 EX-32.1 hrtx-ex321_6.htm EX-32.1 9389
7 GRAPHIC gcs5034epko1000001.jpg GRAPHIC 24629
  Complete submission text file 0001564590-20-007973.txt   13722224

Data Files

Seq Description Document Type Size
8 XBRL TAXONOMY EXTENSION SCHEMA hrtx-20191231.xsd EX-101.SCH 57700
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE hrtx-20191231_cal.xml EX-101.CAL 70408
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE hrtx-20191231_def.xml EX-101.DEF 202996
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE hrtx-20191231_lab.xml EX-101.LAB 531899
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE hrtx-20191231_pre.xml EX-101.PRE 393452
43 EXTRACTED XBRL INSTANCE DOCUMENT hrtx-10k_20191231_htm.xml XML 3232367
Mailing Address 4242 CAMPUS POINT COURT, SUITE 200 SAN DIEGO CA 92121
Business Address 4242 CAMPUS POINT COURT, SUITE 200 SAN DIEGO CA 92121 8582514400
HERON THERAPEUTICS, INC. /DE/ (Filer) CIK: 0000818033 (see all company filings)

EIN.: 942875566 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-33221 | Film No.: 20674234
SIC: 2834 Pharmaceutical Preparations